Haridas B. Rode

1.5k total citations
49 papers, 1.2k citations indexed

About

Haridas B. Rode is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Haridas B. Rode has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Organic Chemistry, 19 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Haridas B. Rode's work include Synthesis and biological activity (13 papers), Catalytic C–H Functionalization Methods (12 papers) and Tuberculosis Research and Epidemiology (9 papers). Haridas B. Rode is often cited by papers focused on Synthesis and biological activity (13 papers), Catalytic C–H Functionalization Methods (12 papers) and Tuberculosis Research and Epidemiology (9 papers). Haridas B. Rode collaborates with scholars based in India, Germany and United States. Haridas B. Rode's co-authors include Daniel Rauh, Matthias Rabiller, Jeffrey R. Simard, Sabine Klüter, Christian Grütter, Matthäus Getlik, Stefanie Heynck, Martin L. Sos, Roman K. Thomas and William A. Weiss and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Haridas B. Rode

47 papers receiving 1.2k citations

Peers

Haridas B. Rode
Mingfeng Yu Australia
Radek Jorda Czechia
Mark A. Ashwell United Kingdom
Joseph Schoepfer Switzerland
Céline Cano United Kingdom
Butrus Atrash United Kingdom
Mingfeng Yu Australia
Haridas B. Rode
Citations per year, relative to Haridas B. Rode Haridas B. Rode (= 1×) peers Mingfeng Yu

Countries citing papers authored by Haridas B. Rode

Since Specialization
Citations

This map shows the geographic impact of Haridas B. Rode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haridas B. Rode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haridas B. Rode more than expected).

Fields of papers citing papers by Haridas B. Rode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haridas B. Rode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haridas B. Rode. The network helps show where Haridas B. Rode may publish in the future.

Co-authorship network of co-authors of Haridas B. Rode

This figure shows the co-authorship network connecting the top 25 collaborators of Haridas B. Rode. A scholar is included among the top collaborators of Haridas B. Rode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haridas B. Rode. Haridas B. Rode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rode, Haridas B., et al.. (2024). N,N‐Diarylsulfonamide Reduces Proinflammatory Cytokine Interleukin‐6 Levels in Cells through Nuclear Factor‐κB Regulation. ChemMedChem. 19(13). e202300598–e202300598. 2 indexed citations
2.
Dusthackeer, Azger, et al.. (2024). 3,5-disubstituted pyridines with potent activity against drug-resistant Mycobacterium tuberculosis clinical isolates. Future Medicinal Chemistry. 16(22). 2351–2369.
3.
Sridhar, Balasubramanian, et al.. (2023). Selectfluor Mediated Regioselective Annulation Using Imidazopyridines, Acetophenones and DMF as Carbon Synthon. Advanced Synthesis & Catalysis. 365(21). 3591–3596. 4 indexed citations
4.
Rode, Haridas B., et al.. (2023). A sustainable approach for nickel nanoparticles synthesis: expeditious access to N-heterocycles under heterogeneous condition and photophysical studies. New Journal of Chemistry. 47(17). 8268–8276. 13 indexed citations
5.
Gourishetti, Karthik, et al.. (2023). Iron mediated reductive cyclization/oxidation for the generation of chemically diverse scaffolds: An approach in drug discovery. Bioorganic Chemistry. 139. 106698–106698. 2 indexed citations
6.
Kaul, Grace, et al.. (2022). Pyrvinium Pamoate Potentiates Levofloxacin Against Levofloxacin-Resistant Staphylococcus Aureus. Future Microbiology. 17(18). 1475–1486. 2 indexed citations
7.
8.
Krishna, Vagolu Siva, Amit Choudhari, Manjulika Shukla, et al.. (2019). Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis. European Journal of Medicinal Chemistry. 178. 315–328. 34 indexed citations
9.
Krishna, Vagolu Siva, Manjulika Shukla, Sunil Misra, et al.. (2019). Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis. European Journal of Medicinal Chemistry. 164. 665–677. 26 indexed citations
10.
Thakare, Ritesh, et al.. (2016). Ligand-free Pd-catalysed decarboxylative arylation of imidazo[1,2-a]pyridine-3-carboxylic acids with aryl bromides. RSC Advances. 6(69). 65095–65104. 13 indexed citations
11.
Kotapalli, Sudha Sravanti, et al.. (2015). Identification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound Repository. PLoS ONE. 10(12). e0144018–e0144018. 17 indexed citations
12.
Sos, Martin L., Haridas B. Rode, Stefanie Heynck, et al.. (2010). Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation. Cancer Research. 70(3). 868–874. 175 indexed citations
13.
Klüter, Sabine, Jeffrey R. Simard, Haridas B. Rode, et al.. (2010). Characterization of Irreversible Kinase Inhibitors by Directly Detecting Covalent Bond Formation: A Tool for Dissecting Kinase Drug Resistance. ChemBioChem. 11(18). 2557–2566. 38 indexed citations
14.
Rode, Haridas B., Martin L. Sos, Christian Grütter, et al.. (2010). Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor. Bioorganic & Medicinal Chemistry. 19(1). 429–439. 9 indexed citations
15.
Peifer, Martin, Jonathan M. Weiss, Martin L. Sos, et al.. (2010). Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling. PLoS ONE. 5(1). e8919–e8919. 22 indexed citations
16.
Simard, Jeffrey R., Sabine Klüter, Christian Grütter, et al.. (2009). A new screening assay for allosteric inhibitors of cSrc. Nature Chemical Biology. 5(6). 394–396. 109 indexed citations
17.
Blair, Jimmy A., Daniel Rauh, Charles Kung, et al.. (2007). Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nature Chemical Biology. 3(4). 229–238. 174 indexed citations
18.
Rode, Haridas B., et al.. (2006). Pseudosaccharin Amine Derivatives: Synthesis and Elastase Inhibitory Activity.. ChemInform. 37(5). 4 indexed citations
19.
Rode, Haridas B., et al.. (2005). Synthesis and in vitro evaluation of pseudosaccharinamine derivatives as potential elastase inhibitors. Bioorganic & Medicinal Chemistry. 14(8). 2789–2798. 6 indexed citations
20.
Ghandhi, S. K., Guru Mathur, Haridas B. Rode, & J.M. Borrego. (1984). Fabrication of p+-n junction GaAs solar cells by a novel method. Solid-State Electronics. 27(12). 1149–1150. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026